Ginkgo Bioworks Holdings (DNA) Total Current Liabilities (2020 - 2026)

Ginkgo Bioworks Holdings (DNA) has 7 years of Total Current Liabilities data on file, last reported at $79.6 million in Q1 2026.

• For the quarter ending Q1 2026, Total Current Liabilities fell 31.19% year-over-year to $79.6 million; the trailing twelve-month figure through Mar 2026 stood at $79.6 million (down 31.19% YoY), and the FY2025 full-year result was $96.0 million, down 10.53% from the prior year.
• Total Current Liabilities for Q1 2026 stood at $79.6 million, down from $96.0 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $191.7 million in Q1 2023 and bottomed at $79.6 million in Q1 2026.
• The 5-year median for Total Current Liabilities is $135.0 million (2022), against an average of $137.6 million.
• The widest annual swing landed in 2022, when Total Current Liabilities jumped 11100.25%; it then sank 41.79% in 2025.
• A 5-year view of Total Current Liabilities shows it stood at $173.0 million in 2022, then slipped by 5.26% to $163.9 million in 2023, then slumped by 34.54% to $107.3 million in 2024, then decreased by 10.53% to $96.0 million in 2025, then retreated by 17.06% to $79.6 million in 2026.
• The last three Total Current Liabilities figures came in at $79.6 million (Q1 2026), $96.0 million (Q4 2025), and $115.3 million (Q3 2025), per Business Quant data.

Peer Comparison